DOCSLIB.ORG

Cphi & P-MEC China Exhibition List展商名单version版本20170609

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cphi & P-MEC China Exhibition List展商名单version版本20170609 CPhI & P-MEC China Exhibition List展商名单 Version版本 20170609 Booth/ Company Name/公司中英文名 Product/产品 展位号 SA TOURNAIRE E1A01 Sichuan HuaFaMei Enterprise Co Ltd E1A01 Anuh Pharma E1A03 Muromachi Chemicals Inc E1A04 NOF Corporation E1A05 ScinoPharm Taiwan Ltd E1A08 Azelis E1A18 EDQM/ Council of Europe E1A19 Orthodox Union E1A20 NGL FINE CHEM LIMITED E1A21 Doosan Corporation E1A23 Sarv Bio Labs Pvt Ltd E1A24 Lonza Biologics Inc E1A25 AMRI E1A36 Hetero Labs Limited E1B01 Toronto Research Chemicals Inc E1B02 Savior Lifetec Corporation E1B03 Leawell International Ltd E1B04 Chemwerth Inc. E1B06 Kingchem (Liaoning) Chemical Co., Ltd E1B08 F.I.S. – Fabbrica Italiana Sintetici SpA E1B10 Carbosynth Ltd E1B12 PhosphonicS E1B12 Dasan Medichem E1B18 深圳信立泰药业股份有限公司/Shenzhen Salubris E1B19 Pharmaceuticals Co., Ltd. Dongkook Pharmaceutical Co.,Ltd. E1B20 Sheffield a Kerry Group Business E1B21 Alkaloids Corporation E1B22 Cho-a Pharm Co Ltd. E1B23 DIA Pharmaceutical Co., Ltd. E1B24 BRENNTAG E1B26 Silicycle INC E1B27 Agno Pharma E1B28 Shin Nippon Yakugyo Co., Ltd E1C02 上海卡乐康包衣技术有限公司/Colorcon China E1C03 High Science Co Ltd E1C04 Fischer Chemicals AG E1C10 Sinoway Industrial Co.,Ltd. E1C10 Angelini A.C.R.A.F SPA E1C13 Bolon Pharmachem Co., Ltd. E1C21 Espee Group Innovators E1C22 Newchem Spa E1C23 Namiki Shoji Co., Ltd. E1C24 ZEON CORPORATION E1C25 OPKO HEALTH SPAIN S.L.U. E1C27 珠海联邦制药股份有限公司/The United E1D01 Laboratories International Holdings Ltd. Indena SpA E1D02 Supriya Lifescience Ltd. E1D03 常州艾柯轧辊有限公司/Leo Chemical (Hong Kong) E1D04 Co., Ltd BIOCND Inc. E1D06 Korea Pharmaceutical Traders Association E1D07 Kyongbo Pharmaceutical Co., Ltd. E1D08 Enzychem Lifesciences Corp. E1D09 IL YANG PHARM. E1D10 CKD Bio Corporation E1D11 Alchem International Pvt Ltd E1D14 上海贺利氏工业技术材料有限公司/Heraeus E1D15 Materials Technology Shanghai Ltd. Amano Enzyme China Ltd E1D16 SUNASIA CO., LTD. E1D17 ZF Polpharma SA E1D18 浙江凯普化工有限公司/Zhejiang ChemPacific E1D19 Chemical Co.,Ltd. ERBOZETA S.P.A. E1D22 Sanat Products Limited E1D26 Mediking Pharmaceutical Group Ltd. E1D28 Corel Pharma Chem E1D30 Chirogate International Inc. E1E01 Chunghwa Chemical Synthesis & Biotech Co., E1E01 Ltd. INIST ST CO., LTD. E1E06 HANLIM PHARM. CO., LTD. E1E07 AK & MN BioFarm Co., Ltd. E1E08 Ahngook Pharm E1E09 ILDONG Pharmaceutical Co., Ltd. E1E10 CTCBIO INC. E1E11 DCS Pharma AG E1E20 Merck Chemicals (Shanghai) Co.,Ltd E1E22 PHARMSOL GROUP E1E23 Chemcon E1E24 Lusochimica S.P.A. E1E25 RCA KG E1E26 JSC Olainfarm E1E27 Macco Organiques Spol. s.r.o. E1E28 浙江省化工进出口有限公司/Zhechem Co., Ltd. E1F01 IONS PHARMA. E1F02 Aarti Drugs Limited E1F03 Midas Pharma GmbH Shanghai Representative E1F05 Dongbang Future Tech & Life Co., Ltd. E1F06 Hanmi Pharm. Co., ltd. E1F07 CMG Pharmaceutical CO., LTD. E1F08 SINIL Pharmaceutical Co., Ltd. E1F09 AnyGen Co., Ltd. E1F10 NEXEL Co., Ltd. E1F11 Yonsung Fine Chemicals Co., Ltd. E1F12 EstechPharma Co., Ltd. E1F18 KOA Shoji Co., Ltd. E1F20 Ningbo Fengrui Fine Chemical Ltd. E1F20 APC Pharmaceutical & Chemical Ltd E1F21 Linnea SA E1F23 Novacyl Asia Pacific Ltd E1F26 Lipoid AG E1F27 VIRCHOW PETROCHEMICAL PVT. LTD E1F28 美国药典委员会/U.S. Pharmacopeia Convention E1F29 Caregen Co Ltd E1F30 庄信万丰（上海）催化剂有限公司/Johnson E1F34 Matthey (Shanghai) Catalyst Co., Ltd. 庄信万丰（烟台）化工产品有限公司/Johnson Matthey Research & Development (Yantai) Co., E1F34 Ltd. Chemsphere Technology E1G01 Everlight Chemical Industrial Corporation E1G02 Daewon Pharm E1G03 JEIL PHARMACEUTICAL CO., LTD E1G04 DAE HWA PHARMACEUTICAL CO., LTD. E1G05 Wooshin Labottach Co., Ltd. E1G06 Korea United Pharm Inc. E1G07 Myungmoon Pharm. Co., Ltd. E1G08 Roquette Management (Shanghai) Co., Ltd. E1G21 SCI Pharmtech, Inc E1G22 Louston International Inc. E1G24 Bachem AG E1G26 江苏圣泰科合成化学有限公司/Leading Hero Global E1G28 Holdings Ltd Albemarle E1G31 Lasa Laboratory E1G32 Rettenmaier(Shanghai) Fiber Trading Co.,Ltd. E1G34 抗病毒类、抗肿瘤类、抗感染类和甾体类中间体、原料药和药物制剂及医药合约研发和加工服务 上海创诺医药集团有限公司/Shanghai Desano APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and E1H01 Pharmaceuticals Co., Ltd. pharmaceutical CRO & CDMO service APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and pharmaceutical CRO & CDMO service 培他米松、地塞米松、泼尼松、泼尼松龙、甲泼尼龙、醋酸氢化可的松、螺内酯、氨基酸、GCLE 、7AVCA、头孢地尼、核黄素磷酸钠、甲睾酮、阿替洛尔、尼莫地平、阿加曲班、尼美舒利、阿 德福韦酯、注射用氢化可的松、注射用马来酸阿奇霉素、肝素钠注射液、注射用尿激酶、黄芪皂苷 天津市医药集团有限公司/TIANJIN TIANFA I、II、III、番泻叶提取物、甜菊糖苷、萝卜硫素。Betamethasone Base, Dexamethasone Base, E1H16 PHARMACEUTICALS IMP.&EXP. CORP. Prednisone, Prednisolone, Methylprednisolone, Hydrocortisone Acetate, Spironolactone, Amino Acid, Budesonide, Fluocinolone Acetonide, Fluocinonide, Triamcinolone Base, Triamcinolone Acetonide, Halcinonide, Hydrocortisone Butyrate, GCLE, Cefidinir, Biboflavin-5-Phosphate Sodium, Methyltestosterone, Atenolol, Nimodipine, Argatroban, 注射用青蒿琥酯,盐酸左旋咪唑,双氢青蒿素磷酸哌喹片Artesunate for Injection,Levamisole 桂林南药股份有限公司/Guilin Pharceutical Co.,Ltd. E1H18a HydrochlorideArtesunate for Injection,Levamisole Hydrochloride 盐酸克林霉素,克林霉素磷酸酯,盐酸克林霉素棕榈酸酯,恩替卡韦,盐酸依匹斯汀,盐酸格拉司琼,盐酸 米托蒽醌,盐酸文拉法辛,阿仑膦酸钠Clindamycin HCl,Clindamycin Phosphate,Clindamycin Palmitate Hydrochloride,Entecavir,Epinastine Hydrochloride,Granisetron 重庆凯林制药有限公司/Chongqing Carelife Hydrochloride,Mitoxantrone Hydrochloride,Venlafaxine Hydrochloride,Sodium E1H18b Pharmaceutical Co.,Ltd. AlendronateClindamycin HCl,Clindamycin Phosphate,Clindamycin Palmitate Hydrochloride,Entecavir,Epinastine Hydrochloride,Granisetron Hydrochloride,Mitoxantrone Hydrochloride,Venlafaxine Hydrochloride,Sodium Alendronate 氨甲环酸 富马酸喹硫平 盐酸氯米帕明 阿戈美拉汀Tranexamic acid; Quetiapine Fumarate; 湖南洞庭药业股份有限公司/Hunan Dongting E1H18c Clomipramine Hydrochloride; AgomelatineTranexamic acid; Quetiapine Fumarate; Pharmaceutical Co.,Ltd. Clomipramine Hydrochloride; Agomelatine L-精氨酸,L-精氨酸盐酸盐,L-半胱氨酸盐酸盐一水物,L-胱氨酸,L-组氨酸,L-组氨酸盐酸盐,L-亮氨酸,L- 湖北新生源生物工程股份有限公司/ 酪氨酸L-Arginine, L-Arginine Hcl, L-Histidine, L-Histidine Hcl, L-Cystine, L-Cysteine Hcl Mono, Shine Star （Hubei）Biological Engineering E1H18d L-Leucine, L-TyrosineL-Arginine, L-Arginine Hcl, L-Histidine, L-Histidine Hcl, L-Cystine, L- Co.,Ltd. Cysteine Hcl Mono, L-Leucine, L-Tyrosine 培美曲塞二钠,度他雄胺,硼替佐米,罗库溴铵,醋酸阿比特龙,达比加群,卡格列净,卡非佐米,蔗糖铁,阿 普斯特,托法替布Pemetrexed Disodium, Abiraterone acetate, Bortezomib, Dutasteride, Iron sucrose, Canagliflozin, Carfilzomib, Apremilast, Tofacitinib, Dabigatran etexilate, 重庆医药工业研究院有限责任公司/Chongqing Rocuronium Bromide,119302-20-4,119302-19-1,154229-19-3, 154229-18-2, 842133-18-0, E1H18e Pharmaceutical Research Institute Co., Ltd 540737-29-9, 211915-06-9, 150399-23-8Pemetrexed Disodium, Abiraterone acetate, Bortezomib, Dutasteride, Iron sucrose, Canagliflozin, Carfilzomib, Apremilast, Tofacitinib, Dabigatran etexilate, Rocuronium Bromide,119302-20-4,119302-19-1,154229-19-3, 154229- 18-2, 842133-18-0, 540737-29-9, 211915-06-9, 150399-23-8 江苏万邦生化医药集团有限责任公司/Wanbang E1H18f 胰岛素系列产品InsulinInsulin Biopharmaceuticals 利福平II,利福平,异烟肼,吡嗪酰胺胶囊/片,盐酸乙胺丁醇胶囊/片,丙硫异烟胺肠溶片,异福胶囊/片,异 福酰胺胶囊,乙胺吡嗪利福异烟片II,乙胺利福异烟片Rifampicin Capsule (II) ,Rifampicin Capsule,Isoniazid Tablet,PYRAZINAMIDE CAPSULE/TABLET ,Ethambutol hYDROCHLORIDE 沈阳红旗制药有限公司 /Shenyang hongqi CAPSULE/TABLET ,PROTIONAMIDE ENTERIC-TABLET,RIAMPICIN ISONIAZID E1H18g pharmaceutical Co.,ltd. CAPSULE/TABLET,ISONIAZID RIFAMPICIN PYRAZINAMIDE CAPSULE,ETHAMBUTOL HYDROCHLORIDE PYRAZINAMIDE RIFAMPICIN ISONIAZID TABLET (II) ,ETHAMBUTOL HYDROCHLORIDE RIFAMPICIN ISONIAZID TABLETRifampicin Capsule (II) ,Rifampicin Capsule,Isoniazid Tablet,PYRAZINAMIDE CAPSULE/TABLET ,Ethambutol hYDROCHLORIDE China Chinopharma Ltd. E1H20 赛诺菲（中国）投资有限公司上海分公司/Sanofi E1H22 LLC Velpharm E1H28 Biophore India Pharmaceuticals Pvt. Ltd. E1H29 麦肯锡公司/McKinsey&Company E1H37 Medieye Holding Co., Limited E1H38 Granules India Ltd E1H39 盐酸克林霉素,盐酸克林霉素棕榈酸酯,克林霉素磷酸酯Clindamycin HCl,Clindamycin Palmitate 浙江海翔药业销售有限公司/Zhejiang Hisoar E1K01 HCl,Clindamycin PhosphateClindamycin HCl,Clindamycin Palmitate HCl,Clindamycin Pharmaceutical sales Co.,Ltd. Phosphate 苯磺阿曲库铵,酒石酸布托啡诺,卡培他滨,醋酸卡泊芬净,塞来昔布,苯磺顺阿曲库铵,硫酸氢氯吡格雷, 达托霉素,地氟烷,盐酸右美托咪定,三水多西他赛,碘化油,依托泊苷,钆特酸葡胺,异环磷酰胺,碘克沙 醇,碘佛醇,盐酸伊立替康,盐酸氯胺酮,来曲唑,美司钠,奥美沙坦,奥沙利铂,七氟烷,替加氟,替莫唑胺,托 江苏恒瑞医药股份有限公司/Jiangsu Hengrui 伐普坦,卡莫司汀,度他雄胺,钆布醇,碘海醇,注射用醋酸卡泊芬净,注射用苯磺顺阿曲库铵,吸入用地氟 E1K08 Medicine Co.,Ltd. 烷,多西他赛注射液,方达帕鲁注射液,加巴喷丁胶囊,盐酸伊立替康注射液,来曲唑片,奥沙利铂注射液, 注射用奥沙利铂,吸入用七氟烷,盐酸右美托咪定注射液,盐酸托伐普坦片,注射用塞替派,甲磺酸阿帕 替尼片,碘化油注射液,培门冬酶注射液,替吉奥胶囊,注射用替莫唑胺,注射用唑来膦酸,卡培他滨片,注 射用达托霉素,碘克沙醇注射液,碘海醇注射液,碘佛醇注射液Atracurium Besylate,Butorphanol 江苏豪森药业集团有限公司/Jiangsu Hansoh E1K08 Pharmaceutical Group Co., Ltd. 甲基多巴,加巴喷丁,卡比多巴,依托度酸,普瑞巴林 浙江手心制药有限公司/Zhejiang Chiral Medicine E1K16 METHYLDOPA,GABAPENTIN,CARBIDOPA,ETODOLAC,PREGABALINMETHYLDOPA,GABAPENT Chemicals Co.,Ltd IN,CARBIDOPA,ETODOLAC,PREGABALIN 甲基多巴,加巴喷丁,卡比多巴,依托度酸,普瑞巴林 浙江永太科技股份有限公司/Zhejiang Yongtai E1K16 METHYLDOPA,GABAPENTIN,CARBIDOPA,ETODOLAC,PREGABALINMETHYLDOPA,GABAPENT Technology Co.,Ltd. IN,CARBIDOPA,ETODOLAC,PREGABALIN 维生素E,生物素,辅酶Q10, 盐酸万古霉素,替考拉宁,米格列醇, 达托霉素, 替加环素Vitamin E,D- 浙江医药股份有限公司/Zhejiang Medicine Co., Ltd. E1K18 Biotin, CoQ10, Vancomycin HCl, Teicoplanin, Miglitol, Daptomycin, TigecyclineVitamin E,D- Biotin, CoQ10, Vancomycin HCl, Teicoplanin, Miglitol, Daptomycin, Tigecycline 头孢克肟,头孢地尼,氧氟沙星,左氧氟沙星,盐酸环丙沙星,盐酸克林霉素,拉索拉唑,奥美沙坦,替米沙 坦,UDCA,尼扎替丁,伊贝沙坦, 氟比洛芬, 洛索洛芬钠, 美索巴莫, 瑞巴派特, 盐酸金刚烷胺, 盐酸安非 他酮, 盐酸多奈哌齐, 加巴贲丁, 氟苯尼考, 碘海醇, 氯霉素, 中间体, 化工品Cefixime, Cefdinir, 浙江横店普洛进出口有限公司/ZHEJIANG Ofloxacin, Levofloxacin, Ciprofloxacin HCl, Clindamycin Hydrochloride, Lansoprazole, E1K20 HENGDIAN APELOA IMP. &EXP.CO.,LTD Olmesartan, Telmisartan, UDCA, Nizatidine, Irbesartan, Flurbiprofen, Loxoprofen sodium, Methocarbamol, Rebamipide, Amantadine Hydrochloride, Bupropion Hydrochloride, Donepezil Hydrochloride, Gabapentin, Florfenicol, Iohexol,
Load more

Recommended publications
  • Psychoactive Plants Used in Designer Drugs As a Threat to Public Health
    From Botanical to Medical Research Vol. 61 No. 2 2015 DOI: 10.1515/hepo-2015-0017 REVIEW PAPER Psychoactive plants used in designer drugs as a threat to public health AGNIESZKA RONDZISTy1, KAROLINA DZIEKAN2*, ALEKSANDRA KOWALSKA2 1Department of Humanities in Medicine Pomeranian Medical University Chłapowskiego 11 70-103 Szczecin, Poland 2Department of Stem Cells and Regenerative Medicine Institute of Natural Fibers and Medicinal Plants Kolejowa 2 62-064 Plewiska, Poland *corresponding author: e-mail: [email protected] Summary Based on epidemiologic surveys conducted in 2007–2013, an increase in the consumption of psychoactive substances has been observed. This growth is noticeable in Europe and in Poland. With the ‘designer drugs’ launch on the market, which ingredients were not placed on the list of controlled substances in the Misuse of Drugs Act, a rise in the number and diversity of psychoactive agents and mixtures was noticed, used to achieve a different state of mind. Thus, the threat to the health and lives of people who use them has grown. In this paper, the authors describe the phenomenon of the use of plant psychoactive sub- stances, paying attention to young people who experiment with new narcotics. This article also discusses the mode of action and side effects of plant materials proscribed under the Misuse of Drugs Act in Poland. key words: designer drugs, plant materials, drugs, adolescents INTRODUCTION Anthropological studies concerning preliterate societies have shown that psy- choactive substances have been used for ages. On the individual level, they help to Herba Pol 2015; 61(2): 73-86 A. Rondzisty, K.
    [Show full text]
  • Update on Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis
    J Bras Pneumol. 2015;41(5):454-466 http://dx.doi.org/10.1590/S1806-37132015000000152 REVIEW ARTICLE Update on diagnosis and treatment of idiopathic pulmonary fibrosis José Baddini-Martinez1, Bruno Guedes Baldi2, Cláudia Henrique da Costa3, Sérgio Jezler4, Mariana Silva Lima5, Rogério Rufino3,6 1. Divisão de Pneumologia, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brasil. 2. Divisão de Pneumologia, Instituto do Coração, Hospital das Clínicas, ABSTRACT Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil. Idiopathic pulmonary fibrosis is a type of chronic fibrosing interstitial pneumonia, of 3. Disciplina de Pneumologia e Tisiologia, unknown etiology, which is associated with a progressive decrease in pulmonary Faculdade de Ciências Médicas, function and with high mortality rates. Interest in and knowledge of this disorder have Universidade do Estado do Rio de grown substantially in recent years. In this review article, we broadly discuss distinct Janeiro, Rio de Janeiro, Brasil. aspects related to the diagnosis and treatment of idiopathic pulmonary fibrosis. We 4. Ambulatório de Pneumologia, Hospital list the current diagnostic criteria and describe the therapeutic approaches currently Ana Nery, Salvador, Brasil. available, symptomatic treatments, the action of new drugs that are effective in slowing 5. Ambulatório de Doenças Pulmonares Intersticiais, Hospital do Servidor the decline in pulmonary function, and indications for lung transplantation. Público Estadual de São Paulo, São Keywords: Idiopathic pulmonary fibrosis/diagnosis; Idiopathic pulmonary fibrosis/therapy; Paulo, Brasil. Idiopathic pulmonary fibrosis/rehabilitation. 6. Programa de Pós-Graduação em Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil.
    [Show full text]
  • Product List March 2019 - Page 1 of 53
    Wessex has been sourcing and supplying active substances to medicine manufacturers since its incorporation in 1994. We supply from known, trusted partners working to full cGMP and with full regulatory support. Please contact us for details of the following products. Product CAS No. ( R)-2-Methyl-CBS-oxazaborolidine 112022-83-0 (-) (1R) Menthyl Chloroformate 14602-86-9 (+)-Sotalol Hydrochloride 959-24-0 (2R)-2-[(4-Ethyl-2, 3-dioxopiperazinyl) carbonylamino]-2-phenylacetic 63422-71-9 acid (2R)-2-[(4-Ethyl-2-3-dioxopiperazinyl) carbonylamino]-2-(4- 62893-24-7 hydroxyphenyl) acetic acid (r)-(+)-α-Lipoic Acid 1200-22-2 (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile 207557-35-5 1,1'-Carbonyl diimidazole 530-62-1 1,3-Cyclohexanedione 504-02-9 1-[2-amino-1-(4-methoxyphenyl) ethyl] cyclohexanol acetate 839705-03-2 1-[2-Amino-1-(4-methoxyphenyl) ethyl] cyclohexanol Hydrochloride 130198-05-9 1-[Cyano-(4-methoxyphenyl) methyl] cyclohexanol 93413-76-4 1-Chloroethyl-4-nitrophenyl carbonate 101623-69-2 2-(2-Aminothiazol-4-yl) acetic acid Hydrochloride 66659-20-9 2-(4-Nitrophenyl)ethanamine Hydrochloride 29968-78-3 2,4 Dichlorobenzyl Alcohol (2,4 DCBA) 1777-82-8 2,6-Dichlorophenol 87-65-0 2.6 Diamino Pyridine 136-40-3 2-Aminoheptane Sulfate 6411-75-2 2-Ethylhexanoyl Chloride 760-67-8 2-Ethylhexyl Chloroformate 24468-13-1 2-Isopropyl-4-(N-methylaminomethyl) thiazole Hydrochloride 908591-25-3 4,4,4-Trifluoro-1-(4-methylphenyl)-1,3-butane dione 720-94-5 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine Hydrochloride 28783-41-7 4-Chloro-N-methyl-piperidine 5570-77-4
    [Show full text]
  • Specifications of Approved Drug Compound Library
    Annexure-I : Specifications of Approved drug compound library The compounds should be structurally diverse, medicinally active, and cell permeable Compounds should have rich documentation with structure, Target, Activity and IC50 should be known Compounds which are supplied should have been validated by NMR and HPLC to ensure high purity Each compound should be supplied as 10mM solution in DMSO and at least 100µl of each compound should be supplied. Compounds should be supplied in screw capped vial arranged as 96 well plate format.
    [Show full text]
  • Analysis of Metals in Surface Water Samples
    ENVIRONMENTAL INSTITUTE, s.r.o., Okružná 784/42, 972 41 Koš Annex I Analysis of metals in surface water samples Environmental Institute, s.r.o., Okružná 784/42, 972 41 Koš, Slovakia October 2020 EUWI+, Investigative monitoring of the Dnieper River Basin, October 2020 ENVIRONMENTAL INSTITUTE, s.r.o., Okružná 784/42, 972 41 Koš Surface water samples Cd (ug/L) Pb (ug/L) Hg (ug/L) Ni (ug/L) As (ug/L) Cr (ug/L) Cu (ug/L) Zn (ug/L) Metals – limit values 0.15** 1.2** 0.07*** 4** 24* 9.0* 1.6* 9.6* Table 1: Results of analyses of Sampling point 1 filtered <LOQ <LOQ <LOQ <LOQ 3.38 <LOQ 1.15 4.0 metals in surface water samples. Sampling point 2 filtered 0.547 <LOQ <LOQ 1.845 <LOQ 0.666 1.94 26.5 The values represent dissolved Sampling point 3 filtered <LOQ <LOQ <LOQ <LOQ 1.99 <LOQ 0.89 4.1 concentrations (after filtration of Sampling point 4 filtered <LOQ <LOQ <LOQ 1.33 <LOQ <LOQ 4.21 9.2 the samples). Numbers Sampling point 5 filtered 2.66 <LOQ <LOQ <LOQ <LOQ 2.35 9.39 20.6 highlighted in orange colour Sampling point 6 filtered <LOQ <LOQ <LOQ <LOQ 2.62 <LOQ 4.95 6.9 indicate exceedance of the Sampling point 7 filtered 0.345 <LOQ <LOQ <LOQ <LOQ 0.777 6.06 38.4 toxicity threshold values. Sampling point 8 filtered <LOQ <LOQ <LOQ <LOQ 2.65 <LOQ 1.03 61.7 Sampling point 9 filtered 0.129 <LOQ <LOQ <LOQ 2.29 0.85 5.36 16.4 Sampling point 10 filtered <LOQ <LOQ <LOQ 1.772 <LOQ <LOQ <LOQ 7.9 Sampling point 11 filtered 0.292 <LOQ <LOQ <LOQ <LOQ 1.31 0.82 11.9 Sampling point 12 filtered 0.328 <LOQ <LOQ <LOQ <LOQ 3.89 1.34 2.6 Sampling point 13 filtered <LOQ
    [Show full text]
  • Synthesis of Condensed 1,2,4-Triazolo-Heterocycles
    Chemistry SYNTHESIS OF CONDENSED 1,2,4-TRIAZOLO-HETEROCYCLES MOHAMMED A. E. SHABAN ADEL Z. NASR MAMDOUH A. M. TAHA SUMMARY: Cyclization of 2-hydrazino-1, 3-benzothiazole, 2-hydrozinoquioline, 2-hydrazinolepidine, and 2-hydrazino-pyridine with one-carbon cyclizing agents such as triethyl orthoformate, ethyl chlorofor- mate, urea, phenylthiourea, and carbon disulfide gave 3-substituted-1,2,4-triazolo (3,4, -b) 1, 3-benzothia- zoles, 3-substituted-1,2,4-triazolo (4,3-a) quinolines, 3-substituted-1,2,4-triazolo (4,3-a) quinolines, 3-substituted-1,2,4-triazolo (4,3-a) lepidines and 3-substituted-1,2,4-triazolo (4,3-a) pyridines respectively. Reactions with acetic acid and acetic anhydride gave the corresponding acetyl hydrazines which were cyclized to the 3-methyl 1,2,4-triazolo-heterocyles. Ring closure with phenyl isocyanate and phenyl isothio- cyanate, gave the intermediate 4-phenylsemicarbazides and 4-phenylthiosemicarbazides which, upon fusion, afforded the corresponding 3-oxo- and 3-thioxo-1,2,4-triazolo-heterocyles. The 3-oxo-compounds were also obtained when 2-chloroquinoloni or 2-chlorolepidine was fused with semicarbazide hydrochloride. Key Words: Synthesis, amidrazones, triazolo-heterocycles. INTRODUCTION The synthesis and biological activities of condensed In an attempt to prepare 3-methyl-1,2,4-triazolo (3,4-b) 1,2,4-triazolo (3,4-z) heterocyles have recently been 1,3-benzothiazole (5a) by heating 2-hydrazino-1, 3- reviewed (14). Several condendes 1,2,4-triazolo-hetero- benzothiazole (1a) with an excess of acetic acid or acetic cyles exhibit various biological activities such as fungicidal anhydride, 1,1,2-triacetyl-2-(1,3-benzothiazol-2-yl) hyd- (1,9) bactericidal (1,9) analgesic (4,7,10) anxiolytic (8) razine (3a) was obtained.
    [Show full text]
  • Synthesis of [1,3,2]Dithiazolo[4,5-B][1,2,5]Oxadiazolo[3,4-E]Pyrazines
    General Papers ARKIVOC 2011 (xi) 69-81 Synthesis of [1,3,2]dithiazolo[4,5-b][1,2,5]oxadiazolo[3,4-e]pyrazines Lidia S. Konstantinova,a Vadim V. Popov,a Natalia V. Obruchnikova,a Konstantin A. Lyssenko,b Ivan V. Ananyev,b and Oleg A. Rakitina* aN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect, 47, 119991 Moscow, Russia bA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilov Str., 28, 119991 Moscow, Russia E-mail: [email protected] Abstract The reaction temperature has a strong impact on the results of chlorination of 5,6-bis(tert- butylthio)[1,2,5]oxadiazolo[3,4-b]pyrazine that is readily prepared from 5,6- dichloro[1,2,5]oxadiazolo[3,4-b]pyrazine and sodium tert-butylsulfide. Mono- and bis(sulfenylchlorides) were selectively obtained in high yield and their structure was confirmed by the reaction with morpholine. Treatment of [1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-disulfenyl dichloride with primary aliphatic amines and benzylamine afforded N-substituted [1,3,2]dithiazolo[4,5-b][1,2,5]oxadiazolo[3,4-e]pyrazines in moderate yields. Novel pentacyclic [1,2,5]oxadiazolo[3'',4'':5',6']pyrazino[2',3':5,6][1,2,4]thiadiazino[3,4-b][1,3]benzothiazole, whose structure was confirmed by X-ray diffraction, was obtained by the reaction of this disulfenyl dichloride with 2-aminobenzothiazole. Keywords: Fused 1,3,2-dithiazoles, [1,2,5]oxadiazolo[3,4-b]pyrazines, disulfenyl dichlorides, primary amines, bis(tert-butylthio) derivatives, chlorination Introduction Amongst five-membered
    [Show full text]
  • A Framework for Assurance of Medication Safety Using Machine Learning
    A Framework for Assurance of Medication Safety using Machine Learning Yan Jia1 Tom Lawton2 John McDermid1 Eric Rojas3 Ibrahim Habli1 Abstract— Medication errors continue to be the leading cause of avoidable patient harm in hospitals. This paper sets out a framework to assure medication safety that combines machine learning and safety engineering methods. It uses safety analysis to proactively identify potential causes of medication error, based on expert opinion. As healthcare is now data rich, it is possible to augment safety analysis with machine learning to discover actual causes of medication error from the data, and to identify where they deviate from what was predicted in the safety analysis. Combining these two views has the potential to enable the risk of medication errors to be managed proactively and dynamically. We apply the framework to a case study involving thoracic surgery, e.g. oesophagectomy, where errors in giving beta-blockers can be critical to control atrial fibrillation. This case study combines a HAZOP-based safety analysis method known as SHARD with Bayesian network structure learning and process mining to produce the analysis results, showing the potential of the framework for ensuring patient safety, and for transforming the way that safety is managed in complex healthcare environments. Keywords—medication safety, machine learning, proactive safety management 1. INTRODUCTION Safety analysis is both predictive and reactive. It aims to identify hazards, hazard causes and mitigations, and associated risks before a system is deployed. The system is then monitored during its deployment to manage risks. When systems are used in highly controlled environments, built using components with a long service history, these predictions can be accurate.
    [Show full text]
  • Download Drug Labels List
    Syringe Labelling System Price Per Label Description/Drug Name Item No. Quanitiy Per Pack Pack Abciximab 99801 2 x 500 roll's £6.30 Abidec 100602 2 x 500 roll's £6.30 Acepromazine 99802 2 x 500 roll's £6.30 Acetazolamide 99803 2 x 500 roll's £6.30 Acetylcholine 99804 2 x 500 roll's £6.30 Acetylcysteine 99805 2 x 500 roll's £6.30 Acetylsalicylic Acid 99806 2 x 500 roll's £6.30 Aciclovir 99807 2 x 500 roll's £6.30 ACP/Buprenorphine 100208 2 x 500 roll's £6.30 Actrapid Insulin 99808 2 x 500 roll's £6.30 Adenosine 99809 2 x 500 roll's £6.30 Adrenaline (Top Half Black, Bottom Violet, Violet Text) 99810 2 x 500 roll's £6.30 Adrenaline/Epinephrine 99811 2 x 500 roll's £6.30 Albumin Solution 99812 2 x 500 roll's £6.30 Alchol 99813 2 x 500 roll's £6.30 Alemtuzmab 99814 2 x 500 roll's £6.30 ALERT 100243 2 x 500 roll's £6.30 Alfaxalone 99815 2 x 500 roll's £6.30 Alfentanil 99816 2 x 500 roll's £6.30 Alfentanil 99817 2 x 500 roll's £6.30 Alteplase 99818 2 x 500 roll's £6.30 Amikacin 99819 2 x 500 roll's £6.30 Aminophylline 99820 2 x 500 roll's £6.30 Amiodarone 100194 2 x 500 roll's £6.30 Amoxicillin 100195 2 x 500 roll's £6.30 Amphotericin 99821 2 x 500 roll's £6.30 Ampicillin 99822 2 x 500 roll's £6.30 Antibiotic 99823 2 x 500 roll's £6.30 Anticoagulant 99824 2 x 500 roll's £6.30 Antifungal 100228 2 x 500 roll's £6.30 Antiseptic 99825 2 x 500 roll's £6.30 Aprotinin 99826 2 x 500 roll's £6.30 Aqueous Iodine 99827 2 x 500 roll's £6.30 Arterial 100259 2 x 500 roll's £6.30 Arterial ( Line Label - White with Red Writing) 100176 2 x 500 roll's £6.30 Arterial
    [Show full text]
  • Réglementation De La Pharmacie
    R E C U E I L D E T E X T E S S U R L A P H A R M A C I E Mis à jour le 13 février 2017 par l’Inspection de la pharmacie P R É A M B U L E La réglementation relative à la pharmacie en vigueur en Nouvelle-Calédonie résulte de la coexistence des dispositions adoptées par la Nouvelle-Calédonie au titre de ses compétences en matières d’hygiène publique, de santé et de professions de la pharmacie1, et de celles adoptées par l’Etat au titre de ses compétences en matières de garanties des libertés publiques, de droit civil et de droit commercial2. Sur le contenu du recueil En 1954, la Nouvelle-Calédonie s’est vue étendre les articles L. 511 à L. 520 et L. 549 à L. 665 de l’ancien Livre V relatif à la Pharmacie du code de la santé publique métropolitain par la loi n° 54-418 du 15 avril 1954 étendant aux territoires d'outre-mer, au Togo et au Cameroun certaines dispositions du Code de la santé publique relatives à l'exercice de la pharmacie3, dont les modalités d’application ont été fixées par le décret modifié n° 55-1122 du 16 août 1955 fixant les modalités d'application de la loi n° 54-418 du 15 avril 1954 étendant aux territoires d'outre-mer, au Togo et au Cameroun certaines dispositions du code de la santé publique relatives à l'exercice de la pharmacie4. Depuis sont intervenues la loi- cadre Defferre5, la loi référendaire de 19886 et la loi organique n° 99-209 du 19 mars 1999 dont les apports ont eu pour résultat le transfert de ces articles de la compétence de l’Etat à la compétence de la Nouvelle-Calédonie, permettant à celle-ci de s’en approprier et de les modifier à sa guise par des délibérations du congrès de la Nouvelle-Calédonie7.
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2020 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]